MedTrace Logo

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

NCT03032848 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2019-05-01

No results posted yet for this study

Summary

To evaluate the difference of three vaginal estrogens creams comparative with placebo on improvement of hormonal cytology, local and systemic climacteric complaints, as well as its endometrial security.

Conditions

  • Vaginitis Atropic
  • Pelvic Organ Prolapse
  • Endometrial Hyperplasia

Interventions

DRUG

Conjugated Estrogen

use of 1 gram per day

DRUG

Promestriene

use of 1 gram per day

DRUG

Estriol

use of 1 gram per day

DRUG

Vaginal Moisturizer - Cream

use of 1 gram per day

Sponsors & Collaborators

  • Universidade Federal do Paraná

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-26
Primary Completion
2016-12-20
Completion
2016-12-26

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03032848 on ClinicalTrials.gov